Dianthus Therapeutics | MGTA - Stock


Dianthus Therapeutics reported 384K in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Akebia Therapeutics USD 13M 2.61M Mar/2026
Avita Medical AUD 6.93M 614K Dec/2025
Celltrion KRW 122.94B 2.59T Dec/2025
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Moderna USD 146M 7M Mar/2026
Organigram Holdings CAD 132.71M 8.76M Dec/2025
Organon & Co USD 1.37B 33M Mar/2026
Pharma Mar EUR 53.12M 2.48M Mar/2026
Qiagen NV USD 301.89M 11.66M Dec/2025
Revvity USD 387.5M 8.01M Mar/2026
Sartorius EUR 827.1M 34.9M Mar/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Viatris USD 3.93B 72.2M Mar/2026
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 6.28B 553.86M Mar/2026